Brii Biosciences Limited
BRIBF
$0.2406
$0.00944.07%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.48% | 17.92% | 0.86% | -1,969.99% | 0.31% |
| Total Depreciation and Amortization | -0.48% | -59.73% | -0.86% | -10.07% | 0.32% |
| Total Amortization of Deferred Charges | -0.71% | -- | -- | -- | 0.36% |
| Total Other Non-Cash Items | -0.48% | 166.10% | -0.86% | 134.55% | -0.31% |
| Change in Net Operating Assets | 0.48% | -- | -- | -- | -0.31% |
| Cash from Operations | 0.48% | 34.10% | 0.86% | 5.48% | -0.31% |
| Capital Expenditure | 0.47% | -225.76% | 0.94% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.48% | 29.18% | -0.86% | 59.37% | 0.31% |
| Cash from Investing | -0.48% | 28.80% | -0.86% | 59.06% | 0.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 2.27% | 0.00% | 28.21% | 0.00% |
| Issuance of Common Stock | 0.00% | -76.74% | 0.00% | -12.24% | 0.00% |
| Repurchase of Common Stock | 0.00% | -- | -- | -- | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -39.23% | 0.00% | -312.08% | 0.00% |
| Cash from Financing | 0.49% | -14.02% | 0.88% | 28.21% | -0.30% |
| Foreign Exchange rate Adjustments | 0.48% | -182.32% | -0.84% | 742.86% | -0.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.48% | 110.75% | -0.86% | 7,671.73% | 0.34% |